Preliminary discussions are underway with an american pharmaceutical cie to test a drug for ARSACS (preclinical trial). More information to follow.
A consortium of ARSACS researchers from several countries (Canada, Germany, Netherlands, France, Italy and Turkey) file a letter of intent as part of the E-Rare3 competition. More information to follow.
Olivier Audet will present the results of his study at the Congrès de l’Association Québécoise des Sciences de l’Activité Physique – AQSAP Québec 2015 will be held on February 6 and 7 at Laval University. His study, funded by the Foundation, is to determine the impact of a regular training program on the physical condition and symptoms of spasticity on ARSACS patients.
Audrey Bouchard and Danny Laberge took advantage of the holiday season to sell Christmas cakes. Their initiative raised $1050 for ARSACS research. Thank you to both of you and to your family members and friends in Saguenay and Pont-Rouge for your support to the cause.
Activities are currently underway to conduct chronic studies on the administration of a drug in ARSACS mice. A preliminary study was done in 2013 and had positive results. This time, the studies will be done over a longer period of time. More details to come.
CIHR Institute of Genetics to participate in the 2015 "European Research Projects on Rare Diseases" Joint Transnational Call.Read More
The International Ataxia Research Conference (ARC) will be held from March 25th to 28th,2015 at the Beaumont Estate, Windsor, UK. Prior to the conference,an ARSACS meeting will be held at the same location on March 23rd to discuss the outcome measures in ARSACS
The Ataxia Charlevoix-Saguenay Foundation was founded in 2006 to finance scientific research on Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS).Learn more
Again this year, with Mr. Jacques Bougie as the honorary president, the Dîner des Producteurs had a great success raising over $700,000 for the ARSACS reseach.Learn more
ARSACS is a debilating hereditary and progressive childhood neurological disorder.Learn more